Thyrocare Technologies Limited (BOM:539871)
475.60
-4.60 (-0.96%)
At close: May 12, 2026
Thyrocare Technologies Market Cap
Thyrocare Technologies has a market cap or net worth of 75.7 billion as of May 12, 2026. Its market cap has increased by 95.47% in one year.
Market Cap
75.70B
Enterprise Value
74.01B
Revenue
7.92B
Ranking
n/a
PE Ratio
54.34
Stock Price
475.60
Market Cap Chart
Since May 9, 2016, Thyrocare Technologies's market cap has increased from 33.20B to 75.70B, an increase of 128.00%. That is a compound annual growth rate of 8.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 76.43B | 7.67% |
| Dec 31, 2025 | 70.99B | 46.48% |
| Dec 31, 2024 | 48.46B | 42.22% |
| Dec 29, 2023 | 34.08B | 4.19% |
| Dec 30, 2022 | 32.71B | -44.08% |
| Dec 31, 2021 | 58.49B | 21.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| One Global Service Provider | 8.49B |
| Chandan Healthcare | 6.22B |
| Star Imaging and Path Lab | 1.49B |
| Modern Diagnostic & Research Centre | 1.21B |
| Invicta Diagnostic | 1.14B |
| Aspira Pathlab & Diagnostics | 657.72M |
| Family Care Hospitals | 204.18M |
| Clinitech Laboratory | 85.13M |